Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Samantha MaWhinney

Concepts (499)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
81
2024
2453
4.730
 Why?
Anti-HIV Agents
37
2022
663
3.900
 Why?
Adenine
14
2022
218
1.980
 Why?
Organophosphates
11
2022
90
1.810
 Why?
Tenofovir
17
2022
204
1.780
 Why?
Emtricitabine
14
2021
147
1.740
 Why?
Acquired Immunodeficiency Syndrome
10
2023
212
1.670
 Why?
HIV-1
29
2021
768
1.560
 Why?
Dried Blood Spot Testing
8
2022
71
1.300
 Why?
Medication Adherence
15
2022
531
1.160
 Why?
Pre-Exposure Prophylaxis
7
2021
179
0.740
 Why?
Viral Load
19
2022
405
0.700
 Why?
Middle Aged
66
2023
26605
0.590
 Why?
Directly Observed Therapy
1
2017
14
0.590
 Why?
Adult
62
2023
30375
0.560
 Why?
Anti-Retroviral Agents
5
2019
207
0.520
 Why?
Pulmonary Disease, Chronic Obstructive
1
2023
907
0.510
 Why?
Aging
9
2023
1611
0.510
 Why?
Humans
122
2024
114045
0.510
 Why?
Male
77
2023
55396
0.500
 Why?
Leukocytes, Mononuclear
8
2021
489
0.490
 Why?
Female
77
2022
59324
0.470
 Why?
Unsafe Sex
2
2012
57
0.440
 Why?
Viremia
6
2022
122
0.430
 Why?
Cytochrome P-450 CYP3A
2
2012
61
0.410
 Why?
Exercise
6
2022
1642
0.400
 Why?
Lamivudine
2
2012
59
0.400
 Why?
Zidovudine
2
2012
77
0.400
 Why?
CD8-Positive T-Lymphocytes
8
2018
686
0.390
 Why?
T-Lymphocytes, Cytotoxic
6
2014
154
0.390
 Why?
Sofosbuvir
4
2022
53
0.380
 Why?
Oligopeptides
2
2012
234
0.380
 Why?
Prospective Studies
23
2022
6195
0.380
 Why?
Models, Statistical
5
2022
595
0.360
 Why?
Atazanavir Sulfate
4
2016
41
0.360
 Why?
Sustained Virologic Response
3
2019
33
0.350
 Why?
Mobile Applications
2
2022
140
0.350
 Why?
CD4-Positive T-Lymphocytes
9
2016
959
0.350
 Why?
HIV Integrase Inhibitors
2
2024
62
0.350
 Why?
Receptors, CCR5
6
2013
54
0.340
 Why?
Emigrants and Immigrants
1
2012
107
0.340
 Why?
Pyridines
2
2012
419
0.340
 Why?
Dideoxynucleotides
2
2012
14
0.330
 Why?
Cytidine Triphosphate
2
2012
14
0.330
 Why?
Phosphorous Acids
2
2019
12
0.330
 Why?
Levonorgestrel
2
2012
31
0.320
 Why?
Antiviral Agents
3
2019
642
0.320
 Why?
Frailty
2
2022
113
0.320
 Why?
Quality of Life
7
2023
2343
0.320
 Why?
Sarcoma, Kaposi
3
2022
68
0.300
 Why?
Antiretroviral Therapy, Highly Active
8
2019
256
0.300
 Why?
Aged
26
2023
18969
0.290
 Why?
Exercise Therapy
3
2020
351
0.290
 Why?
Inflammation
5
2021
2464
0.280
 Why?
Gonadal Steroid Hormones
1
2008
123
0.280
 Why?
Prion Diseases
1
2006
10
0.270
 Why?
Creutzfeldt-Jakob Syndrome
1
2006
13
0.270
 Why?
Deoxyadenine Nucleotides
2
2016
13
0.270
 Why?
Deoxycytosine Nucleotides
2
2016
11
0.270
 Why?
Wasting Disease, Chronic
1
2006
18
0.270
 Why?
Lymph Nodes
6
2017
415
0.270
 Why?
Coronary Artery Bypass
7
2004
196
0.260
 Why?
Young Adult
16
2020
10444
0.260
 Why?
Gene Expression
2
2014
1417
0.250
 Why?
Simian Immunodeficiency Virus
2
2016
70
0.250
 Why?
Body Composition
4
2024
590
0.250
 Why?
Simian Acquired Immunodeficiency Syndrome
2
2016
68
0.240
 Why?
Lymphocyte Activation
9
2018
1036
0.240
 Why?
Cross-Over Studies
4
2020
439
0.240
 Why?
HIV
4
2019
208
0.230
 Why?
Population Surveillance
3
2002
385
0.230
 Why?
Contraceptives, Postcoital
1
2004
2
0.230
 Why?
CD4 Lymphocyte Count
10
2020
256
0.230
 Why?
Cohort Studies
8
2023
4883
0.230
 Why?
Cytokines
3
2009
1824
0.230
 Why?
Advance Care Planning
2
2021
195
0.220
 Why?
Physical Fitness
2
2015
180
0.220
 Why?
Lipopolysaccharide Receptors
2
2021
81
0.210
 Why?
Patient Dropouts
2
2015
66
0.210
 Why?
HIV Integrase
1
2024
67
0.210
 Why?
Fluorenes
2
2020
38
0.200
 Why?
RNA, Viral
9
2014
565
0.200
 Why?
HIV Seropositivity
3
2012
109
0.200
 Why?
Telerehabilitation
1
2022
29
0.200
 Why?
Lymphoid Tissue
3
2008
62
0.200
 Why?
High-Intensity Interval Training
1
2022
18
0.200
 Why?
Benzimidazoles
2
2020
137
0.190
 Why?
Hepatitis C
2
2022
218
0.190
 Why?
Cell Phone
1
2022
76
0.190
 Why?
Hair
2
2018
65
0.190
 Why?
Protease Inhibitors
2
2020
96
0.180
 Why?
Fees and Charges
1
2000
9
0.180
 Why?
Mitochondria, Muscle
1
2021
92
0.180
 Why?
Polyphosphates
4
2022
33
0.170
 Why?
Ritonavir
2
2012
71
0.170
 Why?
Hyperlipidemias
1
2021
121
0.170
 Why?
Interleukin-10
2
2021
293
0.170
 Why?
Biomarkers
6
2021
3397
0.170
 Why?
Advance Directives
1
2021
69
0.170
 Why?
Costs and Cost Analysis
1
2000
196
0.170
 Why?
ADP-ribosyl Cyclase 1
4
2013
36
0.160
 Why?
Thymine Nucleotides
2
2016
15
0.160
 Why?
Myocardial Ischemia
1
2000
239
0.160
 Why?
Colorado
7
2022
4090
0.160
 Why?
Transgender Persons
1
2021
134
0.150
 Why?
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
1
2018
14
0.150
 Why?
Cytomegalovirus Infections
2
2015
180
0.150
 Why?
Hepatitis C, Chronic
2
2019
150
0.150
 Why?
Longitudinal Studies
5
2020
2384
0.150
 Why?
Virus Replication
5
2017
395
0.150
 Why?
Blood Chemical Analysis
4
2019
90
0.150
 Why?
Drug Resistance, Viral
1
2019
99
0.150
 Why?
Length of Stay
4
2000
957
0.150
 Why?
Simeprevir
1
2018
8
0.150
 Why?
Raltegravir Potassium
2
2015
16
0.150
 Why?
Heterocyclic Compounds, 3-Ring
1
2018
28
0.150
 Why?
Epitopes, T-Lymphocyte
4
2008
170
0.140
 Why?
Viral Tropism
1
2017
24
0.140
 Why?
Sleep Wake Disorders
1
2020
232
0.140
 Why?
Pharmacogenetics
2
2016
149
0.140
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2021
373
0.140
 Why?
Academic Medical Centers
1
2019
405
0.140
 Why?
AIDS-Related Opportunistic Infections
3
2007
115
0.140
 Why?
Pyrophosphatases
1
2016
22
0.140
 Why?
Risk Factors
11
2021
8614
0.140
 Why?
Deoxyguanine Nucleotides
1
2016
8
0.140
 Why?
Motor Activity
4
2015
635
0.140
 Why?
T-Lymphocytes, Helper-Inducer
1
2017
127
0.140
 Why?
Germinal Center
1
2016
48
0.130
 Why?
Genitalia
1
2016
28
0.130
 Why?
Alanine
3
2021
105
0.130
 Why?
Vaccines, DNA
2
2008
29
0.130
 Why?
Case-Control Studies
7
2016
3003
0.130
 Why?
Ribavirin
1
2016
89
0.130
 Why?
Muscle Strength
1
2018
271
0.130
 Why?
AIDS Vaccines
2
2008
41
0.130
 Why?
HIV Protease Inhibitors
2
2016
64
0.130
 Why?
Mental Health Services
1
2019
316
0.130
 Why?
Purines
1
2016
158
0.130
 Why?
Disease Transmission, Infectious
2
2018
54
0.130
 Why?
Antibodies, Viral
3
2015
520
0.130
 Why?
Rectum
1
2016
151
0.120
 Why?
Biometry
2
2011
62
0.120
 Why?
Sexual and Gender Minorities
1
2017
138
0.120
 Why?
HLA-DR Antigens
3
2012
219
0.120
 Why?
Genitalia, Female
1
2015
37
0.120
 Why?
Gastrointestinal Microbiome
1
2021
502
0.120
 Why?
T-Lymphocytes, Regulatory
1
2017
337
0.120
 Why?
Disease Progression
4
2015
2371
0.120
 Why?
Telemedicine
1
2022
662
0.120
 Why?
Organophosphonates
1
2015
89
0.120
 Why?
Decision Making
1
2021
760
0.120
 Why?
Probability
2
2011
286
0.120
 Why?
Deoxycytidine
1
2015
138
0.110
 Why?
T-Lymphocyte Subsets
3
2015
383
0.110
 Why?
Calcifediol
1
2014
29
0.110
 Why?
Membrane Glycoproteins
3
2013
429
0.110
 Why?
Adolescent
13
2020
17800
0.110
 Why?
Calcitriol
1
2014
53
0.110
 Why?
Patient Compliance
1
2017
524
0.110
 Why?
Microbiota
1
2021
648
0.110
 Why?
Immunoglobulin Variable Region
1
2014
72
0.110
 Why?
Antimicrobial Cationic Peptides
1
2014
75
0.110
 Why?
Chromatography, Liquid
3
2019
345
0.110
 Why?
Emergency Service, Hospital
1
2004
1815
0.110
 Why?
Immunoglobulin G
2
2015
766
0.110
 Why?
Infectious Disease Transmission, Vertical
1
1994
150
0.110
 Why?
Immunologic Factors
1
2015
217
0.100
 Why?
Spleen
1
2014
485
0.100
 Why?
Diabetes Mellitus
1
2020
898
0.100
 Why?
Time Factors
7
2019
6077
0.100
 Why?
Tandem Mass Spectrometry
3
2019
410
0.100
 Why?
Dendritic Cells
2
2008
435
0.100
 Why?
Retrospective Studies
9
2021
12521
0.100
 Why?
Hepatitis A Vaccines
1
2012
15
0.100
 Why?
Cell Movement
3
2016
863
0.100
 Why?
Muscle, Skeletal
1
2021
1468
0.100
 Why?
Hepatitis A
1
2012
26
0.100
 Why?
Benzoxazines
1
2012
28
0.100
 Why?
Sarcopenia
1
2013
63
0.100
 Why?
Mental Disorders
1
2019
889
0.100
 Why?
Cervix Uteri
1
2012
44
0.100
 Why?
Marijuana Smoking
1
2015
224
0.100
 Why?
Sex Factors
5
2018
1706
0.100
 Why?
B-Lymphocytes
1
2016
762
0.100
 Why?
Haplotypes
2
2012
448
0.100
 Why?
Contraceptive Agents
1
2012
54
0.090
 Why?
Hypertension, Pulmonary
1
2022
1736
0.090
 Why?
Contraceptive Agents, Female
1
2012
64
0.090
 Why?
Polymorphism, Genetic
2
2016
610
0.090
 Why?
CD4 Antigens
1
2011
123
0.090
 Why?
Cross-Sectional Studies
8
2019
4402
0.090
 Why?
HIV Seronegativity
1
2010
24
0.090
 Why?
Antacids
1
2010
13
0.090
 Why?
Pyrrolidinones
1
2010
25
0.090
 Why?
Accidental Falls
1
2012
151
0.090
 Why?
Predictive Value of Tests
4
2019
1791
0.090
 Why?
Osteoporosis
1
2013
224
0.090
 Why?
Postmenopause
1
2012
301
0.090
 Why?
Herpesvirus 8, Human
2
2000
61
0.080
 Why?
Diphosphates
2
2021
16
0.080
 Why?
Cytomegalovirus
2
2015
143
0.080
 Why?
Polymorphism, Single Nucleotide
2
2016
1880
0.080
 Why?
Zimbabwe
3
2022
41
0.080
 Why?
Drug Interactions
3
2019
337
0.080
 Why?
Cytotoxicity Tests, Immunologic
3
2003
43
0.080
 Why?
Lung Diseases
1
2015
690
0.080
 Why?
Demography
2
2022
258
0.080
 Why?
Linear Models
3
2020
768
0.080
 Why?
Hepacivirus
2
2022
228
0.080
 Why?
Plasma
1
2009
181
0.070
 Why?
Healthy Volunteers
2
2018
191
0.070
 Why?
Multivariate Analysis
7
2007
1422
0.070
 Why?
Interleukin-12
2
1998
110
0.070
 Why?
Hospitals, Veterans
3
2004
244
0.070
 Why?
Adipocytes
1
2008
188
0.070
 Why?
Sequence Analysis, DNA
1
2009
722
0.070
 Why?
Deer
1
2006
23
0.070
 Why?
Managed Care Programs
1
2007
133
0.070
 Why?
Self Report
2
2021
695
0.070
 Why?
Comorbidity
3
2019
1447
0.070
 Why?
Interferon-gamma
3
2008
719
0.070
 Why?
Treatment Outcome
9
2018
9049
0.060
 Why?
Therapeutic Equivalency
2
2018
18
0.060
 Why?
Interleukin-6
2
2021
673
0.060
 Why?
Physicians, Family
1
2007
201
0.060
 Why?
Preventive Health Services
1
2007
134
0.060
 Why?
T-Lymphocytes
3
2005
1735
0.060
 Why?
Macaca mulatta
2
2016
131
0.060
 Why?
Incidence
4
2012
2314
0.060
 Why?
Hospitalization
3
2022
1762
0.060
 Why?
Molecular Sequence Data
1
2009
2783
0.060
 Why?
Pilot Projects
3
2022
1360
0.060
 Why?
Immunologic Memory
2
2009
313
0.060
 Why?
Immunoenzyme Techniques
1
2005
192
0.060
 Why?
Area Under Curve
2
2018
273
0.060
 Why?
Licensure, Pharmacy
1
2004
1
0.060
 Why?
Northern Ireland
1
2004
7
0.060
 Why?
New York City
2
1994
70
0.060
 Why?
Surveys and Questionnaires
2
2014
4595
0.060
 Why?
Programmed Cell Death 1 Receptor
2
2016
193
0.060
 Why?
Odds Ratio
3
2014
951
0.060
 Why?
Fluorescent Antibody Technique
3
2015
396
0.050
 Why?
Survival Analysis
3
2015
1206
0.050
 Why?
HIV Antibodies
2
2014
49
0.050
 Why?
Patient Satisfaction
1
2007
571
0.050
 Why?
Mutation
1
2014
3338
0.050
 Why?
Conserved Sequence
1
2003
218
0.050
 Why?
Integrases
1
2024
116
0.050
 Why?
Ki-67 Antigen
2
2017
102
0.050
 Why?
Flow Cytometry
3
2015
1075
0.050
 Why?
Quality of Health Care
1
2007
572
0.050
 Why?
Creatinine
3
2018
424
0.050
 Why?
Cells, Cultured
4
2017
3861
0.050
 Why?
Tablets
1
2022
36
0.050
 Why?
Sex Characteristics
1
2007
636
0.050
 Why?
Drug Therapy, Combination
2
2018
949
0.050
 Why?
Mental Health
2
2019
559
0.050
 Why?
Habits
1
2022
36
0.050
 Why?
Drug Prescriptions
1
2004
237
0.050
 Why?
Voltage-Dependent Anion Channel 1
1
2021
9
0.050
 Why?
Angina Pectoris
1
2001
63
0.050
 Why?
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
1
2021
40
0.050
 Why?
Drug Monitoring
1
2022
184
0.050
 Why?
Citrate (si)-Synthase
1
2021
45
0.050
 Why?
Antigens, Viral
3
2014
176
0.050
 Why?
Receptors, Tumor Necrosis Factor, Type II
1
2021
34
0.050
 Why?
Receptors, Tumor Necrosis Factor, Type I
1
2021
73
0.050
 Why?
Diagnosis-Related Groups
1
2000
26
0.040
 Why?
Weight Loss
2
2020
642
0.040
 Why?
Weight Gain
1
2024
453
0.040
 Why?
Hand Strength
1
2021
97
0.040
 Why?
Hemarthrosis
1
2000
11
0.040
 Why?
Actigraphy
1
2020
75
0.040
 Why?
Communicable Diseases
1
2002
127
0.040
 Why?
Death
1
2021
106
0.040
 Why?
HIV Antigens
2
2015
17
0.040
 Why?
Phenotype
3
2016
2784
0.040
 Why?
Heart Valves
1
2000
41
0.040
 Why?
Virus Diseases
1
2002
195
0.040
 Why?
Superoxide Dismutase
1
2021
305
0.040
 Why?
Immunophenotyping
3
2007
274
0.040
 Why?
Age Factors
3
2000
2885
0.040
 Why?
Feasibility Studies
1
2022
735
0.040
 Why?
Benchmarking
1
2020
161
0.040
 Why?
Drug Combinations
1
2020
286
0.040
 Why?
Hemophilia A
1
2000
67
0.040
 Why?
Survivors
1
2022
412
0.040
 Why?
Amino Acid Motifs
2
2014
197
0.040
 Why?
Sickness Impact Profile
1
1999
50
0.040
 Why?
Early Detection of Cancer
1
2022
305
0.040
 Why?
Regression Analysis
2
2007
945
0.040
 Why?
Bayes Theorem
1
2020
327
0.040
 Why?
Aged, 80 and over
2
2021
6306
0.040
 Why?
Capsules
1
2018
36
0.040
 Why?
Likelihood Functions
2
1999
126
0.040
 Why?
Herpesviridae Infections
1
1999
138
0.040
 Why?
Nanomedicine
1
2018
28
0.040
 Why?
Renal Insufficiency
1
2000
137
0.040
 Why?
Severity of Illness Index
3
2000
2537
0.040
 Why?
Machine Learning
1
2021
315
0.040
 Why?
Uganda
1
2018
69
0.040
 Why?
Chemoprevention
1
2018
87
0.040
 Why?
Chemistry Techniques, Analytical
1
2018
18
0.040
 Why?
Drug Compounding
1
2018
89
0.040
 Why?
Metabolic Clearance Rate
1
2018
102
0.040
 Why?
Oxazines
1
2018
25
0.040
 Why?
Computer Simulation
2
2016
873
0.040
 Why?
Adaptation, Physiological
1
2021
484
0.040
 Why?
Heart Diseases
2
2000
329
0.040
 Why?
Histoplasmosis
1
1997
14
0.040
 Why?
Fluconazole
1
1997
16
0.040
 Why?
Internet
1
2002
591
0.040
 Why?
Fibrin Fibrinogen Degradation Products
1
2018
79
0.040
 Why?
Cause of Death
1
2019
362
0.040
 Why?
Primary Health Care
1
2007
1502
0.040
 Why?
Fatigue
1
2019
294
0.040
 Why?
Palatine Tonsil
1
2017
32
0.040
 Why?
Cardiology Service, Hospital
1
1997
27
0.040
 Why?
Inosine Triphosphate
1
2016
3
0.030
 Why?
Anemia, Hemolytic
1
2016
18
0.030
 Why?
Perforin
1
2016
18
0.030
 Why?
Lung
2
2022
3521
0.030
 Why?
Randomized Controlled Trials as Topic
1
2022
1204
0.030
 Why?
Pyridones
1
2018
122
0.030
 Why?
Models, Theoretical
1
2000
513
0.030
 Why?
Guanosine Triphosphate
1
2016
85
0.030
 Why?
Antifungal Agents
1
1997
128
0.030
 Why?
Half-Life
1
2016
141
0.030
 Why?
Animals
4
2016
31565
0.030
 Why?
Lymphocyte Depletion
1
2016
115
0.030
 Why?
Child
6
2017
18401
0.030
 Why?
Eating
1
1999
344
0.030
 Why?
Algorithms
2
2011
1469
0.030
 Why?
Intubation, Intratracheal
1
1998
214
0.030
 Why?
Nucleotides
1
2016
112
0.030
 Why?
Tumor Necrosis Factor-alpha
1
2021
1128
0.030
 Why?
Statistics, Nonparametric
2
2012
384
0.030
 Why?
Spermatozoa
1
2016
84
0.030
 Why?
Peru
1
2016
54
0.030
 Why?
Clinical Protocols
1
1997
232
0.030
 Why?
Forkhead Transcription Factors
1
2016
170
0.030
 Why?
Heart Valve Prosthesis Implantation
1
1998
175
0.030
 Why?
United States
5
2016
12137
0.030
 Why?
South Africa
1
2016
160
0.030
 Why?
Piperazines
1
2018
310
0.030
 Why?
Human Activities
1
2015
18
0.030
 Why?
HEK293 Cells
1
2017
590
0.030
 Why?
Receptors, CXCR4
2
2007
78
0.030
 Why?
Receptors, CXCR5
1
2014
11
0.030
 Why?
Blood
1
2015
94
0.030
 Why?
Receptors, CCR7
1
2014
24
0.030
 Why?
Drug Users
1
2015
41
0.030
 Why?
Registries
1
2022
1764
0.030
 Why?
Drug Administration Schedule
1
2016
714
0.030
 Why?
Adenosine Triphosphate
1
2016
428
0.030
 Why?
Cathelicidins
1
2014
38
0.030
 Why?
Polymerase Chain Reaction
2
2012
990
0.030
 Why?
Substance Abuse, Intravenous
1
2015
100
0.030
 Why?
Complementarity Determining Regions
1
2014
43
0.030
 Why?
Mutation Rate
1
2014
24
0.030
 Why?
Prognosis
1
2021
3315
0.030
 Why?
Energy Metabolism
1
1999
727
0.030
 Why?
Kidney Failure, Chronic
1
1999
489
0.030
 Why?
Gene Expression Regulation, Viral
1
2014
80
0.030
 Why?
Infant, Newborn
2
1994
5038
0.030
 Why?
Aging, Premature
1
2013
11
0.030
 Why?
Insulin-Like Growth Factor Binding Protein 3
1
2013
38
0.030
 Why?
Body Fat Distribution
1
2013
46
0.030
 Why?
Mothers
1
1999
650
0.030
 Why?
Cytotoxicity, Immunologic
2
2007
188
0.030
 Why?
Amino Acid Substitution
1
2014
261
0.030
 Why?
Cardiac Surgical Procedures
1
1997
414
0.030
 Why?
Genotype
2
2012
1757
0.030
 Why?
Child, Preschool
3
1998
9114
0.030
 Why?
Bronchoalveolar Lavage Fluid
1
2015
580
0.030
 Why?
Frail Elderly
1
2013
106
0.030
 Why?
Muscles
1
2013
320
0.020
 Why?
Cyclopropanes
1
2012
81
0.020
 Why?
Alkynes
1
2012
53
0.020
 Why?
Receptors, HIV
1
2011
23
0.020
 Why?
Confidence Intervals
1
2012
302
0.020
 Why?
Disabled Persons
1
2013
130
0.020
 Why?
Postoperative Complications
1
2001
2122
0.020
 Why?
Infant
2
1994
7943
0.020
 Why?
Depression
1
2019
1133
0.020
 Why?
Insulin-Like Growth Factor I
1
2013
286
0.020
 Why?
Follow-Up Studies
2
2015
4392
0.020
 Why?
Epithelial Cells
1
2016
946
0.020
 Why?
Pregnancy Complications, Infectious
1
1994
285
0.020
 Why?
Bone and Bones
1
2013
277
0.020
 Why?
Body Mass Index
2
2013
1957
0.020
 Why?
Geography
1
2011
176
0.020
 Why?
Disease Susceptibility
1
2012
316
0.020
 Why?
North America
1
2011
255
0.020
 Why?
Chi-Square Distribution
2
2002
492
0.020
 Why?
Interleukin-2
2
2003
413
0.020
 Why?
Models, Biological
1
2016
1611
0.020
 Why?
Cell Proliferation
1
2016
2173
0.020
 Why?
Bone Density
1
2013
432
0.020
 Why?
Cost-Benefit Analysis
1
2012
544
0.020
 Why?
Magnetic Resonance Imaging
1
2000
3039
0.020
 Why?
Postoperative Hemorrhage
2
2000
74
0.020
 Why?
Socioeconomic Factors
1
2012
1080
0.020
 Why?
Respiratory Tract Diseases
2
2000
139
0.020
 Why?
DNA, Viral
2
2000
349
0.020
 Why?
Immunosuppressive Agents
1
2012
641
0.020
 Why?
Health Status
2
2004
716
0.020
 Why?
Gene Expression Regulation
1
2016
2322
0.020
 Why?
Personnel Turnover
1
2007
27
0.020
 Why?
Risk Assessment
3
2004
2958
0.020
 Why?
Lymphocyte Count
1
2007
132
0.020
 Why?
Sweating
1
2007
23
0.020
 Why?
DNA Primers
1
2008
508
0.020
 Why?
Hospital Mortality
2
2004
773
0.020
 Why?
Obesity
1
1999
2505
0.020
 Why?
Gender Identity
1
2007
100
0.020
 Why?
Neoplasms
1
2019
2086
0.020
 Why?
Fever
1
2007
280
0.020
 Why?
Health Care Surveys
1
2007
541
0.020
 Why?
DNA
1
2012
1350
0.020
 Why?
Selection Bias
1
2005
33
0.020
 Why?
Acute Disease
1
2007
907
0.010
 Why?
Quality Indicators, Health Care
1
2007
285
0.010
 Why?
Cell Line
2
2001
2629
0.010
 Why?
Base Sequence
1
2008
2114
0.010
 Why?
HLA-A3 Antigen
1
2003
6
0.010
 Why?
HLA-B7 Antigen
1
2003
7
0.010
 Why?
Intraoperative Care
1
2004
33
0.010
 Why?
Double-Blind Method
1
2008
1656
0.010
 Why?
HLA-A2 Antigen
1
2003
35
0.010
 Why?
Superantigens
1
2003
69
0.010
 Why?
Histocompatibility Testing
1
2003
115
0.010
 Why?
Cell Line, Transformed
1
2003
133
0.010
 Why?
Chronic Disease
1
2009
1577
0.010
 Why?
Virus Activation
1
2003
78
0.010
 Why?
Postoperative Period
1
2004
288
0.010
 Why?
Drug Evaluation, Preclinical
1
2003
159
0.010
 Why?
B7-2 Antigen
1
2002
25
0.010
 Why?
Pregnancy
1
1994
5499
0.010
 Why?
Morbidity
1
2004
277
0.010
 Why?
Hospital-Physician Relations
1
2002
2
0.010
 Why?
Parainfluenza Virus 3, Human
1
2002
5
0.010
 Why?
Community Medicine
1
2002
5
0.010
 Why?
Rotavirus
1
2002
22
0.010
 Why?
CD40 Antigens
1
2002
81
0.010
 Why?
Attitude to Computers
1
2002
26
0.010
 Why?
Streptococcus pyogenes
1
2002
30
0.010
 Why?
Sick Role
1
2001
18
0.010
 Why?
Immunity, Cellular
1
2003
247
0.010
 Why?
HIV Core Protein p24
1
2001
28
0.010
 Why?
Preoperative Care
1
2004
319
0.010
 Why?
Enzyme-Linked Immunosorbent Assay
1
2003
787
0.010
 Why?
Respiratory Syncytial Virus, Human
1
2002
60
0.010
 Why?
Health Services Research
1
2004
373
0.010
 Why?
Phosphorus Radioisotopes
1
2000
27
0.010
 Why?
Community-Acquired Infections
1
2002
139
0.010
 Why?
Antigens, CD
1
2002
440
0.010
 Why?
United States Department of Veterans Affairs
1
2004
561
0.010
 Why?
Hemophilia B
1
2000
36
0.010
 Why?
Knee
1
2000
51
0.010
 Why?
Elbow
1
2000
52
0.010
 Why?
Synovial Membrane
1
2000
74
0.010
 Why?
Ankle
1
2000
70
0.010
 Why?
Seasons
1
2002
440
0.010
 Why?
Hyperplasia
1
2000
163
0.010
 Why?
Research Design
1
2005
919
0.010
 Why?
Activities of Daily Living
1
2001
348
0.010
 Why?
Calorimetry, Indirect
1
1999
69
0.010
 Why?
Diet Records
1
1999
76
0.010
 Why?
Fathers
1
1999
43
0.010
 Why?
Mice, Transgenic
1
2003
1947
0.010
 Why?
Lymphocyte Culture Test, Mixed
1
1998
41
0.010
 Why?
Erythrocyte Transfusion
1
2000
161
0.010
 Why?
Cost Control
1
1998
39
0.010
 Why?
Anthropometry
1
1999
183
0.010
 Why?
Absorptiometry, Photon
1
1999
224
0.010
 Why?
Puberty
1
1999
135
0.010
 Why?
Radiography
1
2000
803
0.010
 Why?
Reproducibility of Results
1
2005
2764
0.010
 Why?
Analysis of Variance
1
2000
1218
0.010
 Why?
Streptokinase
1
1996
10
0.010
 Why?
Phytohemagglutinins
1
1996
27
0.010
 Why?
Postoperative Care
1
1998
223
0.010
 Why?
Tetanus Toxoid
1
1996
37
0.010
 Why?
Candida
1
1996
32
0.010
 Why?
Cell Division
1
1998
754
0.010
 Why?
Survival Rate
1
2000
1638
0.010
 Why?
Exercise Test
1
1999
547
0.010
 Why?
Antigens, Bacterial
1
1996
111
0.010
 Why?
Disease-Free Survival
1
1997
618
0.010
 Why?
Nuclear Proteins
1
1999
591
0.010
 Why?
Logistic Models
1
2000
1829
0.010
 Why?
Adipose Tissue
1
1999
545
0.010
 Why?
Databases, Factual
1
1999
1125
0.010
 Why?
Patient Selection
1
1997
629
0.010
 Why?
Prevalence
1
1999
2247
0.010
 Why?
Recombinant Proteins
1
1996
1228
0.010
 Why?
Mice
1
2003
14843
0.000
 Why?
MaWhinney's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (499) concept(s)
_
Co-Authors Expand Description
See all (65) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)